- link Copy Url - [ Share on twitter ](https://twitter.com/intent/tweet?text=Novartis Ranks Fourth in Fortune’s “Change the World” List and Moves up in Dow Jones Sustainability Index https://www.3blmedia.com/markdownify/node/106381?absolute=1&via=3blnews "link to 3 B L Media's Twitter") - [ Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/106381?absolute=1 "link to 3 B L Media's Linkedin") - [ Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/106381?absolute=1 "link to 3 B L Media's Facebook") - [ email Share via email ](mailto:?subject=Novartis Ranks Fourth in Fortune’s “Change the World” List and Moves up in Dow Jones Sustainability Index&body=ESG News from Novartis https://www.3blmedia.com/markdownify/node/106381?absolute=1 "Share via email") [Awards, Ratings & Rankings](/CSR-News/awards-ratings-rankings) # Novartis Ranks Fourth in Fortune’s “Change the World” List and Moves up in Dow Jones Sustainability Index ##### Novartis has again been recognized for its commitment to doing well by doing good in key global rankings. Sep 11, 2017 9:35 AM ET Campaign: [Novartis – science based innovation for better patient outcomes](/node/76218) ![](/sites/default/files/styles/carousel_2x/public/images/Novartis-Cart19-12-2.jpg) ![](/sites/default/files/styles/carousel_2x/public/images/DSCF4945_1_0-2.jpg) ![](/sites/default/files/styles/carousel_2x/public/images/DSCF4951_1_0-2.jpg) ![](/sites/default/files/styles/carousel_2x/public/images/DSCF4961_9_0-2.jpg) ![](/sites/default/files/styles/carousel_2x/public/images/DSCF4972_8_0-2.jpg) ![](/sites/default/files/styles/carousel_2x/public/images/DSCF5002_7_0-2.jpg) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/Novartis-Cart19-12-2.jpg?h=a610a299) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/DSCF4945_1_0-2.jpg?h=199d8c1f) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/DSCF4951_1_0-2.jpg?h=199d8c1f) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/DSCF4961_9_0-2.jpg?h=199d8c1f) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/DSCF4972_8_0-2.jpg?h=199d8c1f) ![](/sites/default/files/styles/carousel_thumbnail_x2/public/images/DSCF5002_7_0-2.jpg?h=199d8c1f) September 11, 2017 /3BL Media/ - Novartis has again been recognized for its commitment to doing well by doing good in key global rankings. *Fortune’s* “Change the World” list, published online on Thursday, September 7, placed Novartis in fourth place out of 50 companies listed. The list, now in its third year, recognizes companies that have a positive social impact through activities that are part of their core business strategy. This is the second time that Novartis is being recognized; the company was also listed in 2015 for its Healthy Family program in India (Arogya Parivar). Novartis is “finding the right balance between a potent drug pipeline and people-friendly pricing,” writes *Fortune*. Beyond the scientific breakthrough, Novartis is commended for its innovative approach to value-based pricing that focuses on the value medicines deliver with respect to clinical, patient, health system and societal outcomes. *Fortune* also acknowledges Novartis innovative social business models, specifically Novartis Access, a program that offers treatments against chronic diseases to governments and public-sector customers in lower-income countries at a price of USD 1 per treatment per month, and the Healthy Family programs that serve rural populations in lower-income countries through a mix of health education, affordable healthcare products and capacity-building activities. Also released on Thursday, Novartis ranked fourth in the 2017 Dow Jones Sustainability Index (DJSI) World (up from 7th in 2016), and re-entered the DJSI Europe Index for the first time in four years. Novartis is rated as the industry leader in four categories: labor practices, materiality, climate strategy, and environmental reporting. The company also performed strongly versus the industry in new categories, including human rights and impact measurement and valuation. The DJSI assessment has become the gold-standard for assessing the ESG (environmental, social and governance) performance of companies worldwide. Learn more about Novartis’ corporate responsibility commitments and work to expand access to healthcare here on Novartis.com, View *Fortune’s* “Change the World” list here, [http://fortune.com/change-the-world/ ](http://fortune.com/change-the-world/) [![Novartis logo](/sites/default/files/Clients/novartis_logo_012919.jpg)](/profiles/novartis) ### More from Novartis ###### [Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers](/news/energize-first-its-kind-program-increase-access-renewable-energy-pharmaceutical-suppliers) Nov 4, 2021 6:00 AM ET ###### [Novartis and Medicines for Malaria Venture Report Positive Results for Phase 2b Study of Novel Ganaplacide/Lumefantrine Combination in Children With Malaria](/news/novartis-and-medicines-malaria-venture-report-positive-results-phase-2b-study-novel) Sep 29, 2021 3:00 PM ET ###### [Together Against Child Mortality: Novartis and Save the Children Launch Health Project in the Slums of Nairobi](/news/together-against-child-mortality-novartis-and-save-children-launch-health-project-slums-nairobi) Aug 2, 2021 9:00 AM ET ###### [Novartis Pledges 10-year Commitment With Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and Other Leading Organizations to Co-create Effective, Measurable Solutions for Health Equity](/news/novartis-pledges-10-year-commitment-morehouse-school-medicine-26-historically-black) Jul 20, 2021 8:15 AM ET ###### [Novartis and Hewlett Packard Enterprise Join Forces to Advance Novartis Global Health Efforts](/news/novartis-and-hewlett-packard-enterprise-join-forces-advance-novartis-global-health-efforts) Jun 23, 2021 12:10 PM ET ###### [Novartis Reaches Milestone Delivery of 1 Billion Courses of Antimalarial Treatment](/news/novartis-reaches-milestone-delivery-1-billion-courses-antimalarial-treatment) May 18, 2021 2:15 AM ET ###### [Novartis Inaugurates Innovative Watershed Project in India to Increase Water Availability](/news/novartis-inaugurates-innovative-watershed-project-india-increase-water-availability) Mar 22, 2021 10:30 AM ET ###### [Novartis and the Bill & Melinda Gates Foundation Collaborate to Discover and Develop an Accessible in Vivo Gene Therapy for Sickle Cell Disease](/news/novartis-and-bill-melinda-gates-foundation-collaborate-discover-and-develop-accessible-vivo) Feb 17, 2021 1:15 AM ET